vialroom

#tirzepatide 2026-01-15

Thursday16 messages3 participantstimes are UTC
Highlights from this day
  • lipase_lore — the switch felt like a step down at first and then caught up around week 7 18:36
  • lipase_lore — no gap when i switched, took the last semaglutide dose and started this a week later, anyway 18:37
  • rae_labels — why does everyone talk about 7.5 and not 10 18:38
  • rae_labels — SURMOUNT was the weight programme and SURPASS was diabetes, thats the split people mix up 18:47
  • lipase_lore — licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does, still working it out 19:44
LL

the sweet spot argument is really about effect per side effect, not a magic number

SURMOUNT is weight

the switch felt like a step down at first and then caught up around week 7

🎉12

no gap when i switched, took the last semaglutide dose and started this a week later, anyway

RL

why does everyone talk about 7.5 and not 10

transit-times.csv
373 rows · not retained in the public archive

SURMOUNT was the weight programme and SURPASS was diabetes, thats the split people mix up

RL

SURMOUNT-1 versus SURPASS-2, which one was the weight trial

LL

licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does, still working it out

i argued the sweet spot was nonsense and then spent 6 months at 7.5 not needing more

AA

the two compounds arent interchangeable week for week even if the effect ends up similar

AA

is the sweet spot argument about effect or about side effects

ok so dual agonist, GIP as well as GLP-1, thats the whole difference in one line